Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-16

FDA Approved: TRACLEER — Supplemental Application (Actelion Pharmaceuticals US, Inc.)

View source ↗

Summary

FDA approved a supplemental application for TRACLEER (bosentan) from Actelion Pharmaceuticals US, Inc., marking an update to the drug's labeling. The approval i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRACLEER (bosentan)

Snippet

SUPPL AP for TRACLEER (BOSENTAN)